Tbx6 Gene Expression for Cardiac Cell Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for inducing cardiac progenitor cells and cardiomyocytes from pluripotent stem cells are inefficient and require serum or special culture conditions, with high costs and instability in reproducibility, particularly lacking serum-free conditions and applicability to human cells.
Innovation Solution
A method involving the expression of the Tbx6 gene in pluripotent stem cells using a lentiviral vector regulated by doxycycline, allowing for the differentiation into cardiac progenitor cells under serum-free conditions and subsequent induction of cardiomyocytes by suppressing Tbx6 expression, utilizing a tetracycline-regulated gene expression system.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional methods using serum or special culture conditions are employed to induce cardiac progenitor cells and cardiomyocytes from pluripotent stem cells, then the induction can proceed, but the costs are high and reproducibility is poor
Solution Approach 1:
The invention changes the chemical parameters of the culture medium by replacing serum-containing media with a defined serum-free medium comprising specific growth factors (bFGF, IGF-1, TGF-α) and cytokines (Activin A, BMP4) at optimized concentrations. This parameter change eliminates batch-to-batch variability inherent in serum-based media, thereby improving reproducibility while reducing costs through standardized formulations.
Solution Approach 2:
The invention extracts and eliminates serum from the culture medium, replacing it with a defined composition of essential growth factors and cytokines. This extraction of the problematic serum component removes the source of variability and contamination risks, while the minimal defined medium reduces costs associated with serum procurement and quality control.
2Productivity
If transcriptional factors are introduced to induce cardiac differentiation from pluripotent stem cells, then differentiation can occur, but the method requires serum or special culture conditions which reduce efficiency
Solution Approach 1:
The invention performs preliminary action by pre-optimizing the serum-free culture medium composition before introducing transcriptional factors for cardiac differentiation. The medium is pre-formulated with specific growth factors (bFGF, IGF-1, TGF-α) and cytokines (Activin A, BMP4) at optimal concentrations that prime the pluripotent stem cells for efficient cardiac differentiation, thereby increasing the induction rate while simplifying subsequent culture conditions.
Solution Approach 2:
The invention creates a universal serum-free culture medium that serves multiple functions: maintaining pluripotent stem cell growth, supporting cardiac progenitor cell differentiation, and enabling cardiomyocyte maturation. This multi-functional medium eliminates the need for complex medium changes or special culture conditions during the differentiation process, thereby simplifying the overall procedure while maintaining high productivity.
3Productivity
If conventional methods are used to produce cardiac cells from pluripotent stem cells, then the process can proceed, but the induction rate is low compared to the present method
Solution Approach 1:
The invention ensures continuity of useful action by maintaining optimal differentiation conditions throughout the entire process. The serum-free medium with growth factors (bFGF, IGF-1, TGF-α) and cytokines (Activin A, BMP4) continuously supports cardiac progenitor cell proliferation and differentiation without requiring medium changes or additions, thereby maximizing cell yield and induction rate throughout the culture period.
Solution Approach 2:
The invention enables self-service by designing a serum-free medium system where the included growth factors and cytokines automatically regulate the differentiation process. The medium components work synergistically to promote cardiac differentiation without requiring external intervention or complex monitoring, thereby increasing both induction rate and cell yield through autonomous optimization of the differentiation environment.
Data Source
Figure 1~3
Figure 4~6
Figure 7~9
AI summary
Provided is a method of inducing cardiac progenitor cells or cardiomyocytes from pluripotent stem cells. The present invention provides a method for producing cardiac progenitor cells from pluripotent stem cells, comprising expressing Tbx6 in the pluripotent stem cells. Moreover, the present invention provides a method for producing cardiomyocytes from pluripotent stem cells, comprising: a step of inducing cardiac progenitor cells from pluripotent stem cells, comprising expressing a Tbx6 gene in the pluripotent stem cells; and a step of inducing cardiomyocytes from the cardiac progenitor cells induced in the above step, comprising suppressing the expression of the Tbx6 gene.